Contents

Search

codeine/pseudoephedrine/triprolidine (Actifed with codeine)

DEA controlled substance: class 5. Indications: - symptomatic relief of cough & upper respiratory symptoms Contraindications: - concurrent use of MAO inhibitors Caution: 1) glaucoma 2) hypertension 3) respiratory insufficiency Dosage: 1) adults & children > 12 years: 10 mL every 4-6 hours PRN 2) children 6-12 years: 5 mL every 4-6 hours PRN 3) children 2-6 years: 2.5 mL every 4-6 hours PRN Syrup: pseudoephedrine HCl 30 mg, triprolidine HCl 1.25 mg, codeine phosphate 10 mg/5 mL (120 mL, 240 mL) Adverse effects: - drowsiness, hyperexcitability, dry mouth, constipation, GI upset, blurred vision

General

Ear nose throat combination

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Kaiser Permanente Northern California Regional Drug Formulary, 1998

Components

codeine pseudoephedrine (Sudafed, Afrin, Drixoral, SudoGest) triprolidine (Actidil)